Ranolazine
NDC 31722-668, Ranolazine, tablet, film coated, extended release, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-668
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212788
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-668 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RANOLAZINE500 mg/1
Pharmacologic classes
Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-668-60 | 31722066860 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-668-60) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/82948cdb-73af-4f3f-bd03-628ed0fdbfbaNADAC price for package 31722066860
GET /v1/drugs/nadac/31722066860
Use it
Look up 31722-668 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-668 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-668. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.